Clinical Study

Chronic Kidney Disease Stage Is a Modulator on the Association between High-Sensitivity C-Reactive Protein and Coronary Vasospastic Angina

Table 4

Univariate analysis of variables associated with coronary vasospasm in the study patients.

VariablesAll patientsCKD stage 1CKD stage 2CKD stage 3
Odds ratio95% CIP valueOdds ratio95% CIP valueOdds ratio95% CIP valueOdds ratio95% CIP value

Age, years1.021.008–1.0310.0011.0411.015–1.0670.0021.0191.003–1.0350.0191.0170.947–1.0410.701
Men versus women2.4291.835–3.215<0.0012.4311.778–3.324<0.0012.2451.529–3.297<0.0012.6681.360–5.2340.004
Smoker (yes versus no)2.481.849–3.326<0.0012.6551.920–3.672<0.0012.3551.595–3.475<0.0011.7940.895–3.5980.1
Peripheral white blood cell count, /1000 mm31.2441.143–1.353<0.0011.2211.112–1.339<0.0011.211.087–1.3470.0011.3561.098–1.6750.005
Peripheral monocyte blood cell count, /mm31.0031.002–1.003<0.0011.0031.002–1.004<0.0011.0021.001–1.003<0.0011.0021.001–1.0040.007
Haemoglobin, g/dL1.1521.045–1.2710.0041.1471.026–1.2830.0161.1410.998–1.3040.0531.2070.970–1.5020.091
eGFR, mL/min/1.73 m20.9970.991–1.0030.360.9840.975–0.9940.0010.9920.983–1.0010.0750.9860.966–1.0060.175
hs-CRP, mg/L1.1331.067–1.202<0.0011.151.070–1.236<0.0011.1861.078–1.304<0.0011.090.987–1.2040.089

Statistical significance based on binary logistic regression analysis. CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate; hs-CRP: high-sensitivity C-reactive protein.